Skip to main content
SpringerLink
Log in

Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Tumor necrosis factor (TNF) is a major cytokine involved in inflammatory reaction and a mortality predictor in patients with coronary artery disease (CAD). Plasma levels of soluble TNF (sTNF) depend on the rate of its synthesis but also on its shedding from cell surface, a mechanism mainly regulated by the TNF alpha converting enzyme (TACE or ADAM17). We investigated the relationship between ADAM17 and TNF polymorphisms, circulating levels of shed ADAM17 substrates (sTNF, sTNFR1 and sTNFR2), and cardiovascular risk in a prospective cohort of CAD patients. Five tag single-nucleotide polymorphisms (SNPs) of the ADAM17 gene as well as four previously described TNF SNPs were genotyped in the Atherogene Study composed of 1,400 CAD patients among which 136 died from a cardiovascular (CV) cause. sTNF, sTNFR1, and sTNFR2 concentrations were all significantly elevated in patients with future CV death, independently of other clinical/biological variables. While none of the studied TNF SNPs was associated with sTNF, sTNFR1, nor sTNFR2 levels, the ADAM17 −154A allele was found associated with a 14% increase of sTNF levels as compared to the −154C allele (p = 0.0066). Moreover, individuals carrying the 747Leu allele displayed a borderline increased risk of future cardiovascular death [odds ratio, 2.06 (1.05–4.04), p = 0.03]. These results suggest a role of ADAM17 in the regulation of sTNF plasma levels and identifies ADAM17 gene as a candidate for CAD. Tumor necrosis factor (TNF) is a major cytokine involved in inflammatory reaction and a mortality predictor in patients with coronary artery disease (CAD). We have studied the association of ADAM17 and TNF polymorphisms with circulating levels of shed ADAM17 substrates (sTNF, sTNFR1 and sTNFR2) and with cardiovascular risk in a large population of individuals with CAD (Atherogene Study, n = 1,400). Two newly identified polymorphisms, obtained by a systematic sequencing of the ADAM17 gene, C-154A and Ser747leu, slightly influence respectively sTNF plasma levels and the risk of cardiovascular death.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809

    Article  PubMed  CAS  Google Scholar 

  2. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-{alpha} and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149–2153

    PubMed  CAS  Google Scholar 

  3. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599–2610

    Article  PubMed  CAS  Google Scholar 

  4. Valgimigli M, Ceconi C, Malagutti P, Merli E, Soukhomovskaia O, Francolini G, Cicchitelli G, Olivares A, Parrinello G, Percoco G, Guardigli G, Mele D, Pirani R, Ferrari R (2005) Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation 111:863–870

    Article  PubMed  CAS  Google Scholar 

  5. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, Eriksson P, Hamsten A (1999) A common functional polymorphism (C–>A substitution at position −863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 8:1443–1449

    Article  PubMed  CAS  Google Scholar 

  6. Kroeger KM, Carville KS, Abraham LJ (1997) The −308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391–399

    Article  PubMed  CAS  Google Scholar 

  7. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegard J, Wiman B, Prince JA, de Faire U (2006) Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 187:408–414

    Article  PubMed  CAS  Google Scholar 

  8. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729–733

    Article  PubMed  CAS  Google Scholar 

  9. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733–736

    Article  PubMed  CAS  Google Scholar 

  10. Smalley DM, Ley K (2005) L-selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med 9:255–266

    Article  PubMed  CAS  Google Scholar 

  11. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black R (1998) An essential role for ectodomain shedding in mammalian development. Science 282:1281–1284

    Article  PubMed  CAS  Google Scholar 

  12. Canault M, Peiretti F, Kopp F, Bonardo B, Bonzi MF, Coudeyre JC, Alessi MC, Juhan-Vague I, Nalbone G (2006) The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice: possible contribution to elevated plasma levels of soluble TNF alpha receptors. Atherosclerosis 187:82–91

    Article  PubMed  CAS  Google Scholar 

  13. Canault M, Peiretti F, Mueller C, Kopp F, Morange P, Rihs S, Portugal H, Juhan-Vague I, Nalbone G (2004) Exclusive expression of transmembrane TNF-alpha in mice reduces the inflammatory response in early lipid lesions of aortic sinus. Atherosclerosis 172:211–218

    Article  PubMed  CAS  Google Scholar 

  14. Federici M, Hribal ML, Menghini R, Kanno H, Marchetti V, Porzio O, Sunnarborg SW, Rizza S, Serino M, Cunsolo V, Lauro D, Mauriello A, Smookler DS, Sbraccia P, Sesti G, Lee DC, Khokha R, Accili D, Lauro R (2005) Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. J Clin Invest 115:3494–3505

    Article  PubMed  CAS  Google Scholar 

  15. Shimoda Y, Satoh M, Nakamura M, Akatsu T, Hiramori K (2005) Activated tumour necrosis factor-alpha shedding process is associated with in-hospital complication in patients with acute myocardial infarction. Clin Sci (Lond) 108:339–347

    Article  CAS  Google Scholar 

  16. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F (1998) Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 28:59–66

    Article  PubMed  CAS  Google Scholar 

  17. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, Schlumberger W, Meyer J, AtheroGene Investigators (2001) Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104:25–31

    Article  PubMed  CAS  Google Scholar 

  18. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, Nicaud V, Meyer J, Cambien F, Tiret L, AtheroGene Group (2003) Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 92:515–521

    Article  PubMed  CAS  Google Scholar 

  19. Tregouet DA, Garelle V (2007) A new JAVA interface implementation of THESIAS: Testing Haplotype Effects In Association Studies. Bioinformatics 23:1038–1039

    Article  PubMed  CAS  Google Scholar 

  20. Li J, Ji L (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation. Heredity 95:221–227

    Article  PubMed  CAS  Google Scholar 

  21. Li SS (2005) Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 390:641–653

    Article  PubMed  CAS  Google Scholar 

  22. Hong MG, Bennet AM, de Faire U, Prince JA (2007) Phenotype selection for detecting variable genes: a survey of cardiovascular quantitative traits and TNF locus polymorphism. Eur J Hum Genet 15:609–611

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant of the Programme National de Recherches sur les Maladies Cardiovasculaires 2006 (A06034AS), by the Fondation de France (no. 2006002581), by the “Stiftung Rheinland-Pfalz für Innovation”, Ministry for Science and Education (AZ 15202-386261/545), Mainz, by the MAIFOR grant 2001 of the Johannes Gutenberg-University Mainz, Germany, and by a grant from the French Ministry of Research (ACI IMPBIO no. 032619).

Author information

Authors and Affiliations

  1. INSERM, U626, Marseille, 13385, France

    P. E. Morange, N. Saut, F. Peiretti, G. Nalbone & I. Juhan-Vague

  2. Université de la Méditerranée, Marseille, 13385, France

    P. E. Morange, N. Saut, F. Peiretti, G. Nalbone & I. Juhan-Vague

  3. INSERM, UMR S 525, Paris, 75634, France

    D. A. Tregouet, T. Godefroy, S. Barbaux, O. Poirier & L. Tiret

  4. Université Pierre et Marie Curie-Paris 6, UMR S 525, Paris, 75634, France

    D. A. Tregouet, T. Godefroy, S. Barbaux, O. Poirier & L. Tiret

  5. Bundeswehrzentralkrankenhaus Koblenz, Koblenz, Germany

    C. Bickel

  6. Stadtkrankenhaus Rüsselsheim, Rüsselsheim, Germany

    H. J. Rupprecht

  7. Clinical Chemistry and Laboratory Medicine, Johannes Gutenberg-University Mainz, Mainz, Germany

    K. Lackner

  8. Department of Medicine II, Johannes Gutenberg-University Mainz, Mainz, Germany

    S. Blankenberg

  9. Lab.Hematology CHU Timone. 264 rue Saint-Pierre, Marseille, Cedex 05, 13385, France

    P. E. Morange

Authors
  1. P. E. Morange
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. A. Tregouet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Godefroy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Saut
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Bickel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. J. Rupprecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. Lackner
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Barbaux
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. O. Poirier
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F. Peiretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. G. Nalbone
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. I. Juhan-Vague
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. S. Blankenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. L. Tiret
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. E. Morange.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM Table 1

(DOC 48.0 KB).

ESM Table 2

(DOC 34.5 KB).

ESM Table 3

(DOC 40.0 KB).

ESM Table 4

(DOC 92.0 KB).

Appendix

Appendix

The AtheroGene Group:

Stefan Blankenberg, Hans-Jürgen Rupprecht, Christoph Bickel, Christine Espinola-Klein, Jürgen Meyer (Department of Medicine II), Karl J. Lackner, Dirk Peetz (Institute of Laboratory Medicine and Clinical Chemistry): Johannes Gutenberg-University, Mainz, Germany

Laurence Tiret, Odette Poirier, Tiphaine Godefroy, Claire Perret, Carole Proust, Viviane Nicaud, David-Alexandre Tregouet, François Cambien: INSERM U525, Faculté de Médecine Pitié-Salpêtrière, Paris, France

AtheroGene recruitment centers:

Department of Medicine II, Johannes Gutenberg-University Mainz; Bundeswehrzentralkrankenhaus, Koblenz, Germany

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morange, P.E., Tregouet, D.A., Godefroy, T. et al. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med 86, 1153–1161 (2008). https://doi.org/10.1007/s00109-008-0375-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-008-0375-6

Keywords

Search

Navigation